Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide and dexamethasone in high risk solitary bone plasmacytoma
NCT02544308Phase 3Active, not recruiting
- Sponsor
- University College London
- Start
- Mar 2017
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lenalidomide in solitary bone plasmacytoma (SBP), sponsored by University College London. Started Mar 2017; status: active, not recruiting.
02
Drugs
lenalidomide
03
Conditions
solitary bone plasmacytoma (SBP)
Beyond the preview
Go deeper on NCT02544308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02544308.